What is Can B Corp. (CANB) stock price today?

Can B Corp. (CANB) is currently trading at $0.02, up 16.18% today.

What is CANB P/E ratio?

Can B Corp.'s P/E ratio is -0.11. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is CANB return on equity (ROE)?

Can B Corp.'s return on equity (ROE) is 148.68%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is Can B Corp.'s market cap?

Can B Corp. has a market capitalization of $1.49M.

OTC · Drug Manufacturers - Specialty & Generic

Can B Corp. (CANB) Stock

$0.02 +16.18% OTC: CANB Healthcare

Can B Corp. operates within the United States, specializing in the development, manufacturing, and sale of products derived from cannabidiol (CBD).

Valuation

Metric	Value
Price	$0.02
Market Cap	$1.49M
P/E Ratio	-0.11
P/B Ratio	-0.09
P/S Ratio	0.00
EPS (TTM)	$-0.17
52-Week High	$0.18
52-Week Low	$0.01
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	148.68%
ROA	—
ROCE	37.40%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	-0.65
Current Ratio	0.02

Annual Financials (USD)

Metric	2020	2021	2022	2023	2024
Revenue	$2.0M	$5.0M	$7.0M	$2.0M	$0
Operating Profit	$-8.0M	$-10.0M	$-14.0M	$-7.0M	$-5.0M
Net Profit	$-9.0M	$-12.0M	$-15.0M	$-10.0M	$-10.0M
EPS	$-37.68	$-9.06	$-4.18	$-0.77	$-0.17
Op Margin	-440.8%	-223.0%	-211.9%	-347.3%	—

Balance Sheet (USD)

Metric	2020	2021	2022	2023	2024
Total Assets	$6.0M	$16.0M	$16.0M	$10.0M	$0
Total Liabilities	$2.0M	$11.0M	$13.0M	$11.0M	$13.0M
Cash	$0	$0	$0	$0	$0
Borrowings	$2.0M	$7.0M	$9.0M	$9.0M	$8.0M

Latest News

Kirkland tops North America M&A table in H1 Private Banker International · Jul 30, 2026 Meta stock sinks 10% on earnings miss, 'barely passable' quarter Yahoo Finance · Jul 30, 2026 Morgan Stanley Says Amazon, Microsoft, and Google's AI Spending Will Pay Off Big GuruFocus.com · Jul 30, 2026 RBC Raises Price Target on General Dynamics to $410 From $385, Keeps Sector Perform Rating MT Newswires · Jul 30, 2026 Tourmaline Oil Q2 Earnings Fall 65% YoY MT Newswires · Jul 30, 2026

Cash Flow (USD)

Metric	2020	2021	2022	2023	2024
Operating Cash Flow	$-2.0M	$-7.0M	$-4.0M	$-1.0M	$0
Investing Cash Flow	$0	$-2.0M	$0	$0	$0
Financing Cash Flow	$-1.0M	$0	$0	$0	$0
Net Cash Flow	$0	$0	$0	$0	$0
Free Cash Flow	$-2.0M	$-8.0M	$-4.0M	$-1.0M	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-1.28
FCF Yield	-14.83%
Quick Ratio	0.02
Interest Coverage	-2.68
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ACNNFAusCann Group Holdings Ltd	$0.00	—	-1.63	$1.67M	0.00%
CBDNFCBD Global Sciences Inc.	$0.04	-2.67%	-0.20	$2.07M	0.00%
CIMVFPideka Group Inc.	$0.01	+0.00%	-1.16	$2.51M	0.00%
ETRGFEntourage Health Corp.	$0.00	—	-0.03	$1.23M	0.00%
IWINFIrwin Naturals Inc.	$0.50	+51.52%	-0.18	$1.68M	0.00%

About Can B Corp.

Can B Corp. operates within the United States, specializing in the development, manufacturing, and sale of products derived from cannabidiol (CBD). Its extensive range of hemp-based CBD offerings includes oils, topical creams, moisturizers, isolates, gel capsules, spa items, concentrates, and various lifestyle products. Customers can purchase these goods through the company's official website, automated vending machines, and via partnerships with medical professionals. The firm markets its products under distinct brand names such as Canbiola, Nu Wellness, Seven Chakras, and Pure Leaf Oil. The company, which changed its name from Canbiola Inc. to Can B Corp. in February 2020, was founded in 2005 and is headquartered in Hicksville, New York.

Can B Corp. is headquartered in US.

Can B Corp. (CANB) stock trades at $0.02 with a market capitalization of $1.49M. The stock is valued at a price-to-earnings (P/E) ratio of -0.11, price-to-book of -0.09, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.01 and $0.18, and currently trades 88.9% below its 52-week high.

On profitability, Can B Corp. generates a return on equity (ROE) of 148.68% — well above the market average, a sign of a high-quality business, return on capital employed of 37.40%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: canbcorp.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1173.15 +0.30% JNJ Johnson & Johnson $260.24 +1.47% ABBV AbbVie Inc. $276.46 +1.48% MRK Merck & Company, Inc. Common Stock (new) $146.28 +2.74% UNH UnitedHealth Group Incorporated Common Stock (DE) $381.63 +2.88% NVS Novartis AG $143.79 +0.47% AZN AstraZeneca PLC $159.37 +0.37% TMO Thermo Fisher Scientific Inc $657.30 +0.82% AMGN Amgen Inc. $416.42 +2.20% GILD Gilead Sciences, Inc. $150.73 +2.47% ABT Abbott Laboratories $99.51 +1.04% NVO Novo Nordisk A/S $38.42 +0.62%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides